With Today at Ms.—a daily newsletter from the team here at Ms. magazine—our top stories are delivered straight to your Inbox every afternoon, so you’ll be informed and ready to fight back.

BY CARRIE N. BAKER | While widely known as an abortion pill, mifepristone is very effective for treating fibroids and may also be effective for treating endometriosis and depression. Yet the drug is not available to use for these serious conditions because the FDA tightly restricts the medication due to intense anti-abortion pressure. But that may soon change.

BY JUSTYN HINTZE | With the rise of women, people of color and nonbinary people in STEM, we are seeing more inclusive products come to market that deeply understand the diversity of bodies and health, especially via FemTech: software and technology companies aimed at addressing women’s health needs.

BY CARRIE N. BAKER | New revelations confirm suspicions that the Trump administration limited an FBI investigation into sexual assault allegations against Supreme Court nominee Brett Kavanaugh.

The National Women’s Law Center is calling for the Senate Judiciary Committee examine how the FBI and Trump’s White House Counsel conducted the supplemental investigation. They are demanding the Senate Judiciary Committee hold public hearings and commit to publicly releasing the full extent of the FBI’s findings and disclosures to Donald Trump’s White House counsel related to its investigation.